Archit OrganosysBOM:524640 +4.90%63 EBITDA Margin % is 12.12% as of Mar. 2026, which is 2% above its 10-year median of 11.83. GuruFocus rates BOM:524640 with a GF Score™ of 63/100 and a GF Value™ of ₹55.11 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 1,579 Chemicals companies, Archit Organosys ranks better than 65.42% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Archit Organosys's EBITDA for the
three
months ended in Mar. 2026 was ₹44 Mil. Archit Organosys's Revenue for the
three
months ended in Mar. 2026 was ₹365 Mil. Therefore, Archit Organosys's EBITDA margin for the quarter that ended in Mar. 2026 was 12.12%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Archit Organosys EBITDA Margin % Related Terms
Archit Organosys EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Archit Organosys's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Archit Organosys's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Archit Organosys EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Archit Organosys's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Archit Organosys's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Archit Organosys (BOM:524640) has a EBITDA Margin % of 12.12% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Archit Organosys and its competitors. This is near median its historical median of 11.83. According to the industry distribution chart, Archit Organosys ranks #546 out of 1579 companies in the Chemicals industry, placing it in the top 34.6%.
Is Archit Organosys' EBITDA Margin % too high?
Archit Organosys' current EBITDA Margin % of 12.12% is near median its 10-year median of 11.83. The Chemicals industry median EBITDA Margin % is 9.63. Archit Organosys' value of 12.12% is 25.9% above this industry median. Based on the distribution chart, Archit Organosys ranks #546 out of 1579 companies in the Chemicals industry, which is above the industry midpoint. Overall, Archit Organosys has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Archit Organosys' EBITDA Margin % compare to DOW?
According to the Chemicals industry distribution chart, Archit Organosys ranks #546 out of 1579 companies for EBITDA Margin %. This puts Archit Organosys in the upper half of its industry. The industry median EBITDA Margin % is 9.63. Archit Organosys' value of 12.12% is 25.9% above this benchmark. While the company's 10-year median is 11.83 vs. the industry median of 9.63, Archit Organosys has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,579 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Archit Organosys's current EBITDA Margin % of 12.12% is 25.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Archit Organosys and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Archit Organosys's current EBITDA Margin % is 12.12%, which is near median its own 10-year median of 11.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Archit Organosys stock overvalued right now?
Based on GuruFocus' analysis, Archit Organosys (BOM:524640) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹55.11, compared to a current price of ₹63.84 — trading 15.8% above its estimated fair value. The current EBITDA Margin % is 12.12%, which is near median its 10-year median of 11.83 and 25.9% above the Chemicals industry median of 9.63. Archit Organosys' overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Archit Organosys (BOM:524640), the current EBITDA Margin % is 12.12% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Archit Organosys (BOM:524640) Overvalued in 2026?
Based on GuruFocus' analysis, Archit Organosys stock appears to be overvalued.
The current stock price of ₹63.84 is trading 15.8% above its estimated GF Value™ of ₹55.11.
GuruFocus considers Archit Organosys to be Modestly Overvalued.
Key valuation signals for BOM:524640:
EBITDA Margin %: 12.12% (near median its 10-year median of 11.83)
GF Value™: ₹55.11 vs. price of ₹63.84 (15.8% above fair value)
Industry Position: 25.9% above the Chemicals median (#546 of 1579)
No single metric tells the full story. See the BOM:524640 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Archit Organosys Ltd is mainly engaged in the manufacturing and selling of various chemical products, including alkali chemicals, inorganic chemicals, organic chemicals, pesticides and insecticides, dyes, and dyestuff. The company mainly manufactures and trades chemicals such as Monochloro Acetic Acid (MCA), Sodium Monochloro Acetate (SMCA), Chloroacetyl Chloride, and Trichloroacetyl Chloride (TCAC). It operates in a single segment identified as manufacturing and trading of dyes, chemicals, and pigments. Geographically, it derives the majority of its revenue from India and also exports products to other countries.
63GF Score
Get the complete analysis for BOM:524640
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524640 has been successfully added to your 
